4//SEC Filing
Abdul-Ahad Wajdi 4
Accession 0001493152-22-021324
CIK 0001460702other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:17 PM ET
Size
13.3 KB
Accession
0001493152-22-021324
Insider Transaction Report
Form 4
Abdul-Ahad Wajdi
VP, R&D, CSO
Transactions
- Award
Stock Option (Right to Buy)
2022-07-11+80,000→ 80,000 totalExercise: $0.51Exp: 2032-07-11→ Common Stock (80,000 underlying)
Footnotes (1)
- [F1]Shares underlying the stock option vest over three years in equal annual installments from the date of grant.
Documents
Issuer
Qualigen Therapeutics, Inc.
CIK 0001460702
Entity typeother
Related Parties
1- filerCIK 0001812749
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 4:17 PM ET
- Size
- 13.3 KB